Novartis Investigative Site

Wigan WN6 9EP

0 studies enrolling now · 2 studies all time

What they study most

Psoriatic Arthritis

Studies at this site

• Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis — Completed
• Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis — Completed